Skip to main content

Psychiatric Diseases

  • Chapter
  • First Online:

Abstract

The interaction between psychic functioning and somatic expression is long known and studied. The common ectodermal embryonic origin of the central nervous system and the skin, in addition to several possible emotional and social languages attributable to the skin, make this organ a scenario for physical and mental health manifestations, as well as a territory of personal, social, and cultural expression. Skin-related complaints correspond to up to 58% of the reasons for consultation in primary health care services, and a quarter of these patients have associated psychological distress. Psychodermatology studies the psychiatric manifestations that derive from skin diseases, the triggering and aggravating factors of the dermatosis, the influence of stress and drugs, and the social prejudice and emotional damage resulting from this interaction. This chapter addresses skin complaints resulting from psychiatric illnesses (i.e., those where the genesis of skin manifestations can be primarily attributable to psychic functioning), its epidemiology, and theories that seek to explain the etiopathogenesis, clinical and laboratory findings, and dermatologic, psychotherapeutic, and psychopharmacologic management of psychodermatosis.

This is a preview of subscription content, log in via an institution.

Notes

  1. 1.

    In this case, synonymia is given by cause-effect approximation – habit control disorder leading to hair behavior.

  2. 2.

    Morgellons disease is a term coined in 2002 by Mary Leitao, founder of the Morgellons Research Foundation ( www.morgellons.org ). With the advent of the internet, patients go researching for symptoms on the web and self-diagnose, which consists of delusional infestation, when they believe to be infested by inanimate objects, usually multicolored fibers of uncertain origin, but also food, nanotechnology products, fungi, bacteria, etc. The disease is not recognized in the scientific community, but eventually became a mass phenomenon – the first disease “transmitted” via the internet.

References

  1. Santos Júnior A, Andrade MGGG, Zeferino AB, et al. Prevalência de dermatoses na rede básica de saúde de Campinas, São Paulo-Brasil. An Bras Dermatol. 2007;82(5):419–24.

    Article  Google Scholar 

  2. Lowell BA, Froelich CD, Federman DG, et al. Dermatology in primary care: prevalence and patient disposition. J Am Acad Dermatol. 2001;45(2):250–5.

    Article  CAS  PubMed  Google Scholar 

  3. Royal College of General Practitioners. Morbidity statistics from general practice: 4th National Study 1991–92. London: HMSO; 1995. p. 54–6.

    Google Scholar 

  4. Julian CG. Dermatology in general practice. Br J Dermatol. 1999;141:518–20.

    Article  CAS  PubMed  Google Scholar 

  5. Solomon BA, Collins R, Silverberg NB, Glass AT. Quality of care: issue or oversight in health care reform? J Am Acad Dermatol. 1996;34:601–7.

    Article  CAS  PubMed  Google Scholar 

  6. Taborda MLV, Weber MB, Freitas ES. Avaliação da prevalência de sofrimento psíquico em pacientes com dermatoses do espectro dos transtornos psicocutâneos. An Bras Dermatol. 2005;80(4):351–4.

    Article  Google Scholar 

  7. Savin J, Cotterill J. Psychocutaneous disorders. In: Champion RH, Burton JL, Ebling FJ, editors. Textbook of dermatology. Oxford: Blackwell Scientific; 1992. p. 2479–96.

    Google Scholar 

  8. Azambuja RD, Rocha TN, Conrado LA, et al. Psicodermatologia: pele mente e emoções. In: Sociedade Brasileira de Dermatologia. [Org.: Roberto Doglia Azambuja, Tânia Nely Rocha]. 1st. São Paulo: AC Farmacêutica; 2014.

    Google Scholar 

  9. Koblenzer CS. Psychocutaneous disease. 1st ed. Orlando: Grune Stratton; 1987.

    Google Scholar 

  10. Koo JYM, Pham CT. Psychodermatology: practical guidelines on pharmacotherapy. Arch Dermatol. 1992;126:381–8.

    Article  Google Scholar 

  11. Higgins EM, Du Vivier AW. Cutaneous disease and alcohol misuse. Br Med Bull. 1994;50:85–98.

    Article  CAS  PubMed  Google Scholar 

  12. Koo J. Psychotropic agents in dermatology. Dermatol Clin. 1993;11:215–24.

    Article  CAS  PubMed  Google Scholar 

  13. Gupta MA, Voorhees JJ. Psychosomatic dermatology: is it relevant? Arch Dermatol. 1990;126:90–3.

    Article  CAS  PubMed  Google Scholar 

  14. Mercan S, Kivanç Altunay I. Psychodermatology: a collaborative subject of psychiatry and dermatology. Turkish J Psychiat. 2006;17(4):305–13.

    Google Scholar 

  15. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Porto Alegre: Artes Médicas; 1992.

    Google Scholar 

  16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.

    Google Scholar 

  17. Torres AR, Fontenelle LF, Shavitt RG, Ferrão YA, do Rosário MC, Storch EA, et al. Comorbidity variation in patients with obsessive–compulsive disorder according to symptom dimensions: results from a large multicenter clinical sample. J Affect Disord. 2016;190:508–16.

    Article  PubMed  Google Scholar 

  18. Ferrão YA, Miguel EC, Stein DJ. Tourette’s syndrome, trichotillomania, and obsessive–compulsive disorder: how closely are they related? Psychiatry Res. 2009;170:32–42.

    Article  PubMed  Google Scholar 

  19. Phillips K, Stein DJ, Rauch S, Hollander E, Fallon B, Barsky A, et al. Should an obsessive–compulsive spectrum Grouping of disorders be included in dsm-v? Depression Anxiety. 2010;27:528–55.

    Article  PubMed  Google Scholar 

  20. Lovato L, Ferrão YA, Stein DJ, Shavitt RG, Fontenelle LF, Vivan A, et al. Skin picking and trichotillomania in adults with obsessive-compulsive disorder. Compr Psychiatry. 2012;53(5):562–8.

    Article  PubMed  Google Scholar 

  21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.

    Book  Google Scholar 

  22. Dornelles SIT, Dornelles LA. Escoriações Neuróticas. In: Psicodermatologia. [Org.: Weber MB, Fontes Neto PTL]. Yendis Editora: São Caetano do Sul; 2009. p. 71–84.

    Google Scholar 

  23. Lee CS, Koo JYM. Psychocutaneous diseases. In: Bologna JL, Jorizzo JL, Schaffer JV, editors. Dermatology, 3rd ed. St. Louis, Mo: Elsevier Saunders. 2012. p:127–34.

    Google Scholar 

  24. Gupta MA, Gupta AK, Haberman HF. The self inflicted dermatoses: a critical review. Gen Hosp Psychiatry. 1987;9:45–52.

    Article  CAS  PubMed  Google Scholar 

  25. Van Dijk E, Van Voorst Vader PC. Dermatillomania. Dermatologica. 1979;158:65–71.

    Article  PubMed  Google Scholar 

  26. Silveira VLB. Dermatocompulsões. In: Psicodermatologia. [Org.: Weber MB, Fontes Neto PTL]. Yendis Editora: São Caetano do Sul; 2009. p. 85–93.

    Google Scholar 

  27. Manzoni APDS, Grazziotin TC. Psicodermatoses na infância. In: Psicodermatologia. [Org.: Weber MB, Fontes Neto PTL]. Yendis Editora: São Caetano do Sul; 2009. p. 191–202.

    Google Scholar 

  28. Koblenzer CS. Dermatitis artefata. Clinical features and approaches to treatment. Am J Clin Dermatol. 2000;1(1):47–55.

    Article  CAS  PubMed  Google Scholar 

  29. Gregurek-Novak T, Novak-Bilic G, Vuic M. Dermatitis artefacta: unuasual appearance in an older woman. J Eur A Dermatol Venereol. 2005;19:223–5.

    Article  CAS  Google Scholar 

  30. Sneddon I, Sneddon J. Self-inflicted injury: a follow-up study of 43 patients. Br J Dermatol. 1975;3:527–30.

    Google Scholar 

  31. Gupta MA, Gupta AK. Dermatitis artefacta and sexual abuse. Int J Dermatol. 1993;32:825–6.

    Article  CAS  PubMed  Google Scholar 

  32. Stein DJ, Hollander E. Dermatology and conditions related to obsessive compulsive disorder. J Am Acad Dermatol. 1992;26:237–42.

    Article  CAS  PubMed  Google Scholar 

  33. Hollander MH, Abraham HS. Dermatitis factitia. South Med J. 1973;66:1279–85.

    Article  Google Scholar 

  34. Siddappa K. Trichotillomania. Continuin Med Educ. 2003;69(2):63–8.

    CAS  Google Scholar 

  35. Pereira JM. Tricoses compulsivas. An Bras Dermatol. 2004;79(5):609–18.

    Article  Google Scholar 

  36. Christenson GA, Mackenzie TB, Mitchell JE. Characteristics of 60 adult chronic hair pullers. Am J Psychiatry. 1991;148:365–70.

    Article  CAS  PubMed  Google Scholar 

  37. Abraham LS, Torres FN, Azulay-Abulafia L. Pistas dermatoscópicas para diferenciar a tricotilomania da alopecia areata em placa. An Bras Dermatol. 2010;85(5):723–6.

    Article  PubMed  Google Scholar 

  38. Lachapelle JM, Pierard GE. Traumatic alopecia in trichotillomania: a pathogenic interpretation of histologic lesions in the pilosebaceous unit. J Cutan Pathol. 1977;4:51–67.

    Article  CAS  PubMed  Google Scholar 

  39. Freudenmann RW, Lepping P. Delusional infestations. Clin Microbiol Rev. 2009;22(4):690–732.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Darwin E. Zoonomia. London: J. Johnson; 1796.

    Google Scholar 

  41. Alves CJM, Martelli AC, Ceribelli, Prado RBR, Fonseca MS. Variability of psychological diagnosis in patients with psychogenic excoriation. An Bras Dermatol. [Internet]. 2009. [cited 2016 Apr 25];84(5):534–7.

    Google Scholar 

  42. Lyell A. Delusions of parasitosis. Br J Dermatol. 1983;108:485–99.

    Article  CAS  PubMed  Google Scholar 

  43. Levy H. Les Delires de Zoopathie interne. Paris: These Steinheil; 1906.

    Google Scholar 

  44. Faure H, et al. Sur les parasitoses delirantes. L’Evolution Psychiat. 1957;22:357–75.

    Google Scholar 

  45. Wilson JW, Miller HE. Delusions of parasitosis. Arch Dermatol Syph. 1946;54:39–56.

    Article  CAS  Google Scholar 

  46. Alistair M. Monosymptomatic hypochondriacal psychosis manifesting as delusions do parasitosis. A description of four cases successfully treated with pimozide. Arch Dermatol. 1978;114:940–3.

    Article  Google Scholar 

  47. Berrios GE. Alucinações táteis: aspectos conceituais e históricos. Rev. latinoam. psicopatol. fundam., São Paulo. 2011;14(3):542–62.

    Google Scholar 

  48. Cassal C. Delírio de Parasitose: uma aproximação epistemológica. In: Ensaios filosóficos. [Org.: Guedes W]. Dialógica Editora: São Paulo; 2013. p. 39–48

    Google Scholar 

  49. Koo J, Lee CS. Delusions of parasitosis a dermatologist’s guide to diagnosis and treatment. Am J Clin Dermatol. 2001;22:85–90.

    Google Scholar 

  50. Larsson CE, Otsuka M, Balda AC. Delírio de parasitose (acarofobia): relato de caso em São Paulo(Brasil). An Bras Dermatol. 2000;75:723–8.

    Google Scholar 

  51. Phillips KA, Dufresne RG Jr, Wilkel CS, et al. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol. 2000;42:436–41.

    Article  CAS  PubMed  Google Scholar 

  52. Karakus G, Tamam L. Impulse control disorder comorbidity among patients with bipolar I disorder. Compr Psychiatry. 2011;52(4):378–85.

    Article  PubMed  Google Scholar 

  53. Koo JY, Leon A, Levin EC. Psychodermatology. Semin Cutan Med Surg. 2013;32(2):63.

    Article  PubMed  Google Scholar 

  54. Grant JE, Redden SA, Leppink EW, Odlaug BL. Skin picking disorder with co-occurring body dysmorphic disorder. Body Image. 2015;15:44–8.

    Article  PubMed  Google Scholar 

  55. Hustyi KM, Hammond JL, Rezvani AB, Hall SS. An analysis of the topography, severity, potential sources of reinforcement, and treatments utilized for skin picking in Prader-Willi syndrome. Res Dev Disabil. 2013;34(9):2890–9.

    Article  PubMed  Google Scholar 

  56. Gomes de Alvarenga P, de Mathis MA, Dominguez Alves AC, do Rosário MC, Fossaluza V, Hounie AG, et al. Clinical features of tic-related obsessive-compulsive disorder: results from a large multicenter study. CNS Spectr. 2012;17(2):87–93.

    Article  PubMed  Google Scholar 

  57. Boyd AS, Ritchie C, Likhari S. Munchausen syndrome and Munchausen syndrome by proxy in dermatology. J Am Acad Dermatol. 2014;71(2):376–81.

    Article  PubMed  Google Scholar 

  58. Tucker BT, Woods DW, Flessner CA, Franklin SA, Franklin ME. The skin picking impact project: phenomenology, interference, and treatment utilization of pathologic skin picking in a population-based sample. J Anxiety Disord. 2011;25(1):88–95.

    Article  PubMed  Google Scholar 

  59. Harth W, Mayer K, Linse R. The borderline syndrome in psychosomatic dermatology. Overview and case report. J Eur Acad Dermatol Venereol. 2004;18(4):503–7.

    Article  CAS  PubMed  Google Scholar 

  60. Frecska E, Arato M. Opiate sensitivity test in patients with stereotypic movement disorder and trichotillomania. Prog Neuro-Psychopharmacol Biol Psychiatry. 2002;26(5):909–12.

    Article  CAS  Google Scholar 

  61. O’Sullivan RL, Rauch SL, Breiter HC, Grachev ID, Baer L, Kennedy DN, et al. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry. 1997;42:39–45.

    Article  PubMed  Google Scholar 

  62. Stein DJ, van Heerden B, Hugo C, van Kradenburg J, Warwick J, Zungu-Dirwayi N, et al. Functional brain imaging and pharmacotherapy in trichotillomania. Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuro-Psychopharmacol Biol Psychiatry. 2002;26:885–90.

    Article  CAS  Google Scholar 

  63. Spraker MK. Cutaneous artifactual disease: an appeal for help. Pediatr Clin N Am. 1983;30:659–68.

    Article  CAS  Google Scholar 

  64. Azambuja RD, Rocha TN, Conrado LA, et al. Psicodermatologia: pele, mente e emoções. 1st ed. São Paulo: AC Farmacêutica; 2014.

    Google Scholar 

  65. Stewart RS, Nejtek VA. An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiat. 2003;64:49–52.

    Article  CAS  Google Scholar 

  66. Gupta MA. Emotional regulation, dissociation, and the self-induced dermatoses: clinical features and implications for treatment with mood stabilizers. Clin Dermatol. 2013;31(1):110–7.

    Article  PubMed  Google Scholar 

  67. Harris BA, Sherertz EF, Flowers FP. Improvement of chronic neurotic excoriations with oral doxepin therapy. Int J Dermatol. 1987;26(8):541–3.

    Article  CAS  PubMed  Google Scholar 

  68. Goldsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1986;78(5 Pt 1):867–73.

    Article  CAS  PubMed  Google Scholar 

  69. Deepmala, Slattery J, Kumara N, Delheya L, Berkd M, Deand O, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294–321.

    Article  CAS  PubMed  Google Scholar 

  70. Grant JE, Chamberlain SR, Redden SA, Leppink EW, Odlaug BL, Kim SW. N-acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(5):490–6 doi:https://doi.org/10.1001/jamapsychiatry.2016.0060.

  71. Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking disorder. Am J Psychiatry. 2012;169(11):1143–9.

    Article  PubMed  Google Scholar 

  72. Schuck K, Keijsers GP, Rinck M. The effects of brief cognitive-behaviour therapy for pathologic skin picking: a randomized comparison to wait-list control. Behav Res Ther. 2011;49(1):11–7.

    Article  PubMed  Google Scholar 

  73. Flessner CA, Busch AM, Heideman PW, Woods DW. Acceptance-enhanced behavior therapy (AEBT) for trichotillomania and chronic skin picking: exploring the effects of component sequencing. Behav Modif. 2008;32(5):579–94.

    Article  PubMed  Google Scholar 

  74. Azrin NH, Nunn RG. Habit reversal: a method of eliminating nervous habits and tics. Behav Res Ther. 1973;11:619–28.

    Article  CAS  PubMed  Google Scholar 

  75. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: an experiential approach to behavior change. New York: Guilford Press; 2003.

    Google Scholar 

Additional Suggested Readings

  • Azambuja RD, Rocha TN, Conrado LA, et al. Psicodermatologia: pele mente e emoções. Sociedade Brasileira de Dermatologia. 1ª ed. São Paulo: AC Farmacêutica; 2014.

    Google Scholar 

  • Jafferany M. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiat. 2007;9(3):203–13.

    Article  Google Scholar 

  • Weber MB, Fontes Neto PTL. Psicodermatologia. São Caetano do Sul: Yendis Editora; 2009. p. 71–84.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cecilia Cassal .

Editor information

Editors and Affiliations

Glossary

Anagen phase

The growth phase in the hair growth cycle during which a newly formed hair continues to grow. It is generally the longest phase and is followed by catagen.

Borderline personality disorders (BPDs)

BPD is a pattern of abnormal behavior characterized by extreme fears of abandonment, unstable relationships with other people, sense of self, or emotions, feelings of emptiness, frequent dangerous behavior, and self-harm. Symptoms may be triggered by seemingly normal events. This pattern of behavior typically begins by early adulthood, and occurs across a variety of situations. People with BPD often engage in idealization and devaluation of others, alternating between high positive regard and great disappointment. Substance abuse, depression, and eating disorders commonly coexist with borderline personality disorder. About 6% die by suicide.

Catagen phase

The catagen phase is a short transition stage that occurs at the end of the anagen phase. It signals the end of the active growth of a hair. This phase lasts for about 2–3 weeks while the hair converts to a club hair. A club hair is formed during the catagen phase when the part of the hair follicle in contact with the lower portion of the hair becomes attached to the hair shaft. This process cuts the hair off from its blood supply and from the cells that produce new hair. When a club hair is completely formed, about a 2-week process, the hair follicle enters the telogen phase.

Histopathology

Refers to the microscopic examination of tissue in order to study the manifestations of disease. Specifically, in clinical medicine histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histologic sections have been placed onto glass slides. In contrast, cytopathology examines free cells or tissue fragments.

Intermittent explosive disorder

Intermittent explosive disorder (sometimes abbreviated as IED) is a behavioral disorder characterized by explosive outbursts of anger and violence, often to the point of rage, which are disproportionate to the situation at hand (e.g., impulsive screaming triggered by relatively inconsequential events). Impulsive aggression is unpremeditated, and is defined by a disproportionate reaction to any provocation, real or perceived. Some individuals have reported affective changes prior to an outburst (e.g., tension, mood changes, energy changes).

Munchausen syndrome

A psychiatric factitious disorder whereby those affected feign disease, illness, or psychological trauma to draw attention, sympathy, or reassurance to themselves. Casually referred as hospital addiction syndrome, thick chart syndrome, or hospital hopper syndrome. Munchausen syndrome fits within the subclass of factitious disorder with predominantly physical signs and symptoms, but patients also have a history of recurrent hospitalization, traveling, and dramatic, extremely improbable tales of their past experiences. The condition derives its name from the fictional character Baron Munchausen.

Onychophagy

Also known as nail biting or onychophagia, it is an oral compulsive habit sometimes described as a parafunctional activity, the common use of the mouth for an activity other than speaking, eating, or drinking. Onychophagy is considered an impulse control disorder in the DSM-IV-R, and is classified under obsessive–compulsive and related disorders in the DSM-5. The ICD-10 classifies it as “other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence.”

Paraphilia

Paraphilia (also known as sexual perversion and sexual deviation) is the experience of intense sexual arousal to atypical objects, situations, or individuals. No consensus has been found for any precise border between unusual sexual interests and paraphilic ones. The number and taxonomy of paraphilias is under debate. The DSM-5 has specific listings for eight paraphilic disorders. Several subclassifications of the paraphilias have been proposed, and some argue that a fully dimensional, spectrum or complaint-oriented approach would better reflect the evidence.

Prader–Willi syndrome

A rare genetic disorder whereby seven genes (or some subset thereof) on chromosome 15 (q 11–13) are deleted or unexpressed (chromosome 15q partial deletion) on the paternal chromosome. It was first described in 1956 by Andrea Prader (1919–2001), Heinrich Willi (1900–1971), Alexis Labhart (1916–1994), Andrew Ziegler, and Guido Fanconi of Switzerland. Characteristic of PWS are “low muscle tone, short stature, incomplete sexual development, cognitive disabilities, behavior problems, and a chronic feeling of hunger that can lead to excessive eating and life-threatening obesity.” The incidence of PWS is between 1 in 25,000 and 1 in 10,000 live births.

Psychodermatology

The study of skin disorders using psychological and psychiatric techniques, a subspecialty of dermatology. Frequently treated conditions are psoriasis, eczema, hives, genital and oral herpes, acne, warts, skin allergies, pain and burning sensations, hair loss, and compulsive skin picking and hair pulling. Psychological or psychiatric treatments are the primary treatments for some dermatologic disorders, including trichotillomania and skin picking. Techniques include relaxation, meditation, hypnosis and self-hypnosis, psychotropic medications, biofeedback, and focused psychotherapy.

Schizophrenia

A mental disorder characterized by abnormal social behavior and failure to understand reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices, reduced social engagement and emotional expression, and a lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety disorders, major depressive illness, or substance use disorder. Symptoms typically come on gradually, begin in young adulthood, and last a long time.

Social phobia

Also known as social anxiety disorder (SAD), it is an anxiety disorder characterized by a significant amount of fear in one or more social situations causing considerable distress and impaired ability to function in at least some parts of daily life. These fears can be triggered by perceived or actual scrutiny from others. It is the most common anxiety disorder and one of the most common psychiatric disorders, with 12% of American adults having experienced it.

Telogen phase

The telogen phase is the resting phase of the hair follicle. When the body is subjected to extreme stress, as much as 70% of hair can prematurely enter a phase of rest, called the telogen phase. This hair begins to fall out, causing a noticeable loss of hair. This condition is called telogen effluvium. The club hair is the final product of a hair follicle in the telogen stage, and is a dead, fully keratinized hair. Fifty to 100 club hairs are shed daily from a normal scalp.

Tourette’s disorder

Tourette’s disorder (also called Tourette’s syndrome, Gilles de la Tourette syndrome, GTS or, more commonly, simply Tourette’s or TS) is an inherited neuropsychiatric disorder with onset in childhood, characterized by multiple physical (motor) tics and at least one vocal (phonic) tic. These tics characteristically wax and wane, can be suppressed temporarily, and are preceded by a premonitory urge. Tourette’s is defined as part of a spectrum of tic disorders, which includes provisional, transient, and persistent (chronic) tics.

Trichobezoar

Trichobezoars or human hairballs are complications of trichophagia or eating of the hair. Trichophagia occurs when hair that is pulled out is chewed and then swallowed. The hair will eventually collect in a sufferer’s stomach and will cause stomach problems such as indigestion and pain. Trichophagia is very commonly associated with trichotillomania.

Trichomalacia

A rare genetic condition resulting in patchy hair loss in children. It is an abnormality of the hair shaft and can be due to a compulsive habit of pulling hair on the head or even eyelashes and eyebrows.

Trichotillomania

Also known as trichotillosis or hair pulling disorder, trichotillomania is an obsessive–compulsive disorder characterized by the compulsive urge to pull out one’s hair, leading to hair loss and balding, distress, and social or functional impairment. It may be present in infants, but the peak age of onset is 9–13 years. It may be triggered by depression or stress. Owing to social implications, the disorder is often unreported and it is difficult to accurately predict its prevalence. Common areas for hair to be pulled out are the scalp, eyelashes, eyebrows, legs, arms, hands, nose, and the pubic areas.

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cassal, C., Ferrão, Y. (2018). Psychiatric Diseases. In: Bonamigo, R., Dornelles, S. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-319-33919-1_47

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33919-1_47

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33917-7

  • Online ISBN: 978-3-319-33919-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics